Alto Neuroscience Inc (ANRO)

$3.07 +0.01 (0.33%)
Market Cap 82.84M
Revenue (ttm) 0.00
Net Income (ttm) -61.43M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.14
Volume 73,000
Avg Vol 255,490
Day's Range N/A - N/A
Shares Out 27.07M
Stochastic %K 54%
Beta 1.84
Analysts Strong Sell
Price Target $11.17

Company Profile

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule ph...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 200 0412
Address:
650 Castro Street, Suite 450, Mountain View, United States
Moneywheel
Moneywheel Aug. 9 at 8:15 AM
$ANRO holding strong.
0 · Reply
Love_To_Learn
Love_To_Learn Aug. 8 at 10:23 AM
$ANRO good finished executing few things thank u with your zero volume lol
0 · Reply
Love_To_Learn
Love_To_Learn Aug. 8 at 10:04 AM
$ANRO made a change to your bid 1.65 need to relay something to $SLS cutting the divider line between them n $RFL 1.65 bid is me anro
0 · Reply
BulljackHorseman
BulljackHorseman Aug. 4 at 11:11 PM
$ANRO despite the FUD, this one’s been super steady. Looking forward to it popping soon.
1 · Reply
XkaliburTrading
XkaliburTrading Aug. 3 at 12:27 PM
$ANRO https://newsfilter.io/articles/anro-investors-have-the-opportunity-to-lead-the-alto-neuroscience-securities-fraud-lawsuit-with-faru-9084f238aa903b413fc5914e77d7adb4
1 · Reply
Drugtrade
Drugtrade Jul. 30 at 2:37 PM
$ANRO do your future self a favor and get this in your long port asap. Its the lowest risk to reward in the sector, now confirmed by my ai built market analysis platform
0 · Reply
BiggWilla
BiggWilla Jul. 28 at 2:16 PM
$ANRO when news? or anything
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jul. 25 at 2:19 PM
$ATHE OH MY BABY BOY IS GROWING UP SO FAST!!! $CING is also about to fly. $SLS $PYPD or $ANRO ... what will follow?
0 · Reply
BossTrade
BossTrade Jul. 24 at 6:39 PM
$ANRO Come on man. No debt, fully funded, successful trial(s) Connect the dots Only a matter of time. No looking back once u miss the boat
2 · Reply
Moneywheel
Moneywheel Jul. 24 at 2:20 PM
$ANRO above 3,08$ let’s see if it picks up momentum and volume.
0 · Reply
Latest News on ANRO
Alto Neuroscience, Inc. Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ANRO

Aug 4, 2025, 2:46 PM EDT - 4 days ago

Alto Neuroscience, Inc. Investigated for Breaches of Fiduciary Duty - Contact the DJS Law Group to Discuss Your Rights – ANRO

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. Lawsuit - ANRO

Aug 4, 2025, 8:45 AM EDT - 5 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 19, 2025 in Alto Neuroscience, Inc. Lawsuit - ANRO

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience

Aug 1, 2025, 10:12 AM EDT - 8 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience

Jul 29, 2025, 10:28 AM EDT - 10 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Alto Neuroscience

ALTO NEUROSCIENCE, INC. (NYSE: ANRO) INVESTOR ALERT Investors With Large Losses in Alto Neuroscience, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Jul 22, 2025, 6:25 PM EDT - 17 days ago

ALTO NEUROSCIENCE, INC. (NYSE: ANRO) INVESTOR ALERT Investors With Large Losses in Alto Neuroscience, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights

Alto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment-Resistant Depression

Jun 30, 2025, 8:03 AM EDT - 5 weeks ago

Alto Neuroscience Highlights Peer-Reviewed Publication of PAX-D Study in The Lancet Psychiatry Demonstrating Robust Clinical Effects of Pramipexole for Patients with Treatment-Resistant Depression

Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203

Jun 26, 2025, 7:33 AM EDT - 6 weeks ago

Alto Neuroscience Identifies Biomarker and Reports Positive Pharmacodynamic Results from Exploratory Phase 2 Proof-of-Concept Trial of ALTO-203

Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway

Jun 3, 2025, 6:03 AM EDT - 2 months ago

Alto Neuroscience Announces Acquisition of Novel Dopamine Agonist Combination Product Candidate, Adding Late-Stage Readout in Treatment Resistant Depression Within Current Cash Runway

Alto Neuroscience Presents Data at the 2025 American Society of Clinical Psychopharmacology Annual Meeting Reinforcing Safety and Tolerability Profile for ALTO-300 in Major Depressive Disorder

May 29, 2025, 8:03 AM EDT - 2 months ago

Alto Neuroscience Presents Data at the 2025 American Society of Clinical Psychopharmacology Annual Meeting Reinforcing Safety and Tolerability Profile for ALTO-300 in Major Depressive Disorder

Alto Neuroscience to Participate in Upcoming Investor Conferences

May 28, 2025, 8:03 AM EDT - 2 months ago

Alto Neuroscience to Participate in Upcoming Investor Conferences

Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights

May 14, 2025, 4:10 PM EDT - 3 months ago

Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights

Alto Neuroscience Presents New Data at the Society of Biological Psychiatry Annual Meeting Underscoring Precision Psychiatry Approach

Apr 28, 2025, 8:03 AM EDT - 3 months ago

Alto Neuroscience Presents New Data at the Society of Biological Psychiatry Annual Meeting Underscoring Precision Psychiatry Approach

Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day

Apr 22, 2025, 8:03 AM EDT - 3 months ago

Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day

Alto Neuroscience Reports Full-Year 2024 Financial Results and Recent Business Highlights

Mar 20, 2025, 4:10 PM EDT - 5 months ago

Alto Neuroscience Reports Full-Year 2024 Financial Results and Recent Business Highlights

The Schall Law Firm Invites Investors With Losses In Alto Neuroscience, Inc. To Join A Securities Fraud Investigation

Mar 1, 2025, 11:00 AM EST - 5 months ago

The Schall Law Firm Invites Investors With Losses In Alto Neuroscience, Inc. To Join A Securities Fraud Investigation

Alto Neuroscience Announces U.S. Patent Granted Covering ALTO-300 as a Treatment for Patients with Major Depressive Disorder Characterized by an Electroencephalogram Biomarker

Feb 19, 2025, 8:03 AM EST - 6 months ago

Alto Neuroscience Announces U.S. Patent Granted Covering ALTO-300 as a Treatment for Patients with Major Depressive Disorder Characterized by an Electroencephalogram Biomarker

Alto Neuroscience Announces Favorable Outcome from Interim Analysis of ALTO-300 Phase 2b Major Depressive Disorder Trial

Feb 12, 2025, 8:03 AM EST - 6 months ago

Alto Neuroscience Announces Favorable Outcome from Interim Analysis of ALTO-300 Phase 2b Major Depressive Disorder Trial

The Schall Law Firm Invites Investors With Losses To Join An Investigation Into Alto Neuroscience, Inc. For Securities Fraud

Feb 2, 2025, 11:00 AM EST - 6 months ago

The Schall Law Firm Invites Investors With Losses To Join An Investigation Into Alto Neuroscience, Inc. For Securities Fraud

The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Investigation Into Alto Neuroscience, Inc.

Jan 27, 2025, 11:15 AM EST - 6 months ago

The Schall Law Firm Invites Investors With Losses To Join A Securities Fraud Investigation Into Alto Neuroscience, Inc.

The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Jan 24, 2025, 1:15 PM EST - 7 months ago

The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Jan 22, 2025, 11:45 AM EST - 7 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Alto Neuroscience Inc For Securities Fraud

Jan 3, 2025, 1:30 PM EST - 7 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Alto Neuroscience Inc For Securities Fraud

The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Alto Neuroscience Inc For Securities Fraud

Dec 27, 2024, 12:15 PM EST - 8 months ago

The Schall Law Firm Urges Shareholders With Losses To Join An Inquiry Into Alto Neuroscience Inc For Securities Fraud

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Alto Neuroscience Inc For Securities Fraud

Dec 21, 2024, 12:15 PM EST - 8 months ago

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Alto Neuroscience Inc For Securities Fraud

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Dec 17, 2024, 1:45 PM EST - 8 months ago

The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

Dec 15, 2024, 1:45 PM EST - 8 months ago

The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Securities Fraud

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Possible Securities Fraud

Dec 13, 2024, 2:15 PM EST - 8 months ago

The Schall Law Firm Encourages Shareholder Participation In An Inquiry Into Alto Neuroscience, Inc. For Possible Securities Fraud

The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Alto Neuroscience, Inc.'s Possible Securities Fraud

Dec 11, 2024, 5:15 PM EST - 8 months ago

The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Alto Neuroscience, Inc.'s Possible Securities Fraud

Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology

Dec 11, 2024, 8:03 AM EST - 8 months ago

Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology

Moneywheel
Moneywheel Aug. 9 at 8:15 AM
$ANRO holding strong.
0 · Reply
Love_To_Learn
Love_To_Learn Aug. 8 at 10:23 AM
$ANRO good finished executing few things thank u with your zero volume lol
0 · Reply
Love_To_Learn
Love_To_Learn Aug. 8 at 10:04 AM
$ANRO made a change to your bid 1.65 need to relay something to $SLS cutting the divider line between them n $RFL 1.65 bid is me anro
0 · Reply
BulljackHorseman
BulljackHorseman Aug. 4 at 11:11 PM
$ANRO despite the FUD, this one’s been super steady. Looking forward to it popping soon.
1 · Reply
XkaliburTrading
XkaliburTrading Aug. 3 at 12:27 PM
$ANRO https://newsfilter.io/articles/anro-investors-have-the-opportunity-to-lead-the-alto-neuroscience-securities-fraud-lawsuit-with-faru-9084f238aa903b413fc5914e77d7adb4
1 · Reply
Drugtrade
Drugtrade Jul. 30 at 2:37 PM
$ANRO do your future self a favor and get this in your long port asap. Its the lowest risk to reward in the sector, now confirmed by my ai built market analysis platform
0 · Reply
BiggWilla
BiggWilla Jul. 28 at 2:16 PM
$ANRO when news? or anything
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jul. 25 at 2:19 PM
$ATHE OH MY BABY BOY IS GROWING UP SO FAST!!! $CING is also about to fly. $SLS $PYPD or $ANRO ... what will follow?
0 · Reply
BossTrade
BossTrade Jul. 24 at 6:39 PM
$ANRO Come on man. No debt, fully funded, successful trial(s) Connect the dots Only a matter of time. No looking back once u miss the boat
2 · Reply
Moneywheel
Moneywheel Jul. 24 at 2:20 PM
$ANRO above 3,08$ let’s see if it picks up momentum and volume.
0 · Reply
Ccperk
Ccperk Jul. 24 at 1:20 PM
$ANRO will there be a rinse and repeat like what happened in May when this hit $3 or will this continue to see saw upwards? Who knows what’s going on behind the curtain. 🤷‍♂️
0 · Reply
Slayer69
Slayer69 Jul. 23 at 10:03 PM
$ANRO after a good month of slow gains we finally break 3 bucks and of course some dickhead has to ruin the fun and sell @ $2.88. Hopefully at a loss and by the way, 🖕.
1 · Reply
Drugtrade
Drugtrade Jul. 23 at 8:08 PM
$MRSN $BOLT $ANRO $LIMN all green yet cant hold a gain as usual, might change soon added to bolt, limn today the other i have too much already. Good luck no chance they all tank to zero right?
0 · Reply
Moneywheel
Moneywheel Jul. 23 at 4:42 PM
$ANRO that 3,08$ is a wall. Paytience.
0 · Reply
BossTrade
BossTrade Jul. 23 at 4:19 PM
$ANRO I think $10++ coming
2 · Reply
XQuise
XQuise Jul. 23 at 2:57 PM
$ANRO 3 🤭🤫
0 · Reply
Moneywheel
Moneywheel Jul. 23 at 2:49 PM
$ANRO bulls need a close above 3,08$. Holding strong.
0 · Reply
BiggWilla
BiggWilla Jul. 23 at 2:49 PM
$ANRO ok lfg push to $4 get over this hump
0 · Reply
Moneywheel
Moneywheel Jul. 22 at 6:26 PM
$ANRO now that I made good money out of $GPRO…let’s wait for that one. Holding strong.
0 · Reply
BossTrade
BossTrade Jul. 22 at 2:34 PM
$ANRO 😎
0 · Reply
CARTE_BLANCHE_DEVEREAUX
CARTE_BLANCHE_DEVEREAUX Jul. 18 at 7:34 PM
$ATHE $OUST $SLS $PYPD $ANRO Wishing everybody a great weekend... And a reminder:
3 · Reply
Love_To_Learn
Love_To_Learn Jul. 17 at 7:43 PM
$JAGX bringing u down $PSTV $RFL $SLS $ANRO ! $SINT $NUWE
0 · Reply